SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Andersson Maria) "

Sökning: WFRF:(Andersson Maria)

  • Resultat 51-60 av 2009
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  •  
52.
  •  
53.
  • Baquero, María-Rosario, et al. (författare)
  • Polymorphic mutation frequencies in Escherichia coli : emergence of weak mutators in clinical isolates
  • 2004
  • Ingår i: Journal of Bacteriology. - 0021-9193 .- 1098-5530. ; 186:16, s. 5538-5542
  • Tidskriftsartikel (refereegranskat)abstract
    • Polymorphisms in the rifampin resistance mutation frequency (f) were studied in 696 Escherichia coli strains from Spain, Sweden, and Denmark. Of the 696 strains, 23% were weakly hypermutable (4 x 10(-8) < or = f < 4 x 10(-7)), and 0.7% were strongly hypermutable (f > or = 4 x 10(-7)). Weak mutators were apparently more frequent in southern Europe and in blood isolates (38%) than in urinary tract isolates (25%) and feces of healthy volunteers (11%).
  •  
54.
  • Beck-Friis, Thomas, et al. (författare)
  • Burden of rotavirus infection in hospitalized elderly individuals prior to the introduction of rotavirus vaccination in Sweden
  • 2019
  • Ingår i: Journal of Clinical Virology. - : Elsevier BV. - 1386-6532. ; 119, s. 1-5
  • Tidskriftsartikel (refereegranskat)abstract
    • Background: Rotavirus gastroenteritis (GE) in the elderly has been much less studied than in children. Objectives: The aim of this study was to determine the morbidity and mortality for elderly hospitalized patients with rotavirus GE prior to the introduction of rotavirus vaccination in Sweden, and to investigate the epidemiology of rotavirus genotypes in these patients. Study design: All patients 60 years or older who were hospitalized at Sahlgrenska University Hospital, Gothenburg, Sweden, and were rotavirus positive in a clinical diagnostic test from 2009 to 2016, were included. Medical records were reviewed and rotavirus genotyping real-time PCR was performed. Results: One hundred and fifty-nine patients were included, corresponding to an annual incidence of hospitalization due to rotavirus GE of 16/100 000 inhabitants aged 60 years or older. G2P[4] was the most common genotype, followed by G1P[8] and G4P[8]. The majority of patients had community-onset of symptoms and no or few pre-existing health disorders. Four patients (2.5%) died within 30 days of sampling. Patients with hospital-onset rotavirus GE had a longer median length of stay following diagnosis compared with patients with community-onset of symptoms (19 vs. 5 days, p = 0.001) and higher 30-day mortality (8.6% (3/35) vs. < 1% (1/124), p = 0.03). Conclusions: Hospitalization due to rotavirus GE among the elderly seems to mainly affect otherwise healthy individuals and is associated with low 30-day mortality.
  •  
55.
  • Benderix, Ylva, 1953-, et al. (författare)
  • Barn med neuropsykiatriskt funktionshinder
  • 2009
  • Ingår i: PEDIATRISK OMVÅRDNAD. - Stockholm : LIBER. - 9789147093274 ; , s. 309-315
  • Bokkapitel (övrigt vetenskapligt/konstnärligt)
  •  
56.
  •  
57.
  •  
58.
  • Bergman, Stefan, 1959-, et al. (författare)
  • Alcohol consumption is associated with lower self-reported disease activity and better health-related quality of life in female rheumatoid arthritis patients in Sweden : data from BARFOT, a multicenter study on early RA
  • 2013
  • Ingår i: BMC Musculoskeletal Disorders. - London : BioMed Central. - 1471-2474. ; 14, s. Article 218-
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND: Earlier studies have found a positive effect of alcohol consumption, with a reduced disease activity in rheumatoid arthritis (RA). The aim of this study was to assess alcohol consumption and its association with disease activity and health related quality of life (HRQL) in Swedish RA patients.METHODS: Between 1992 and 2005, 2,800 adult patients were included in the BARFOT study of early RA in Sweden. In 2010 a self-completion postal questionnaire was sent to all 2,102 prevalent patients in the BARFOT study enquiring about disease severity, HRQL, and lifestyle factors. Alcohol consumption was assessed using the validated AUDIT-C questionnaire.RESULTS: A total of 1,238 out of 1,460 patients answering the questionnaire had data on alcohol consumption: 11% were non-drinkers, 67% had a non-hazardous drinking, and 21% were classified as hazardous drinkers. Women who drank alcohol reported lower disease activity and better HRQL, but there were no association between alcohol consumption and disease activity in men. For current smokers, alcohol use was only associated with fewer patient-reported swollen joints. The outcome was not affected by kind of alcohol consumed.CONCLUSIONS: There was an association between alcohol consumption and both lower self-reported disease activity and higher HRQL in female, but not in male, RA patients. © 2013 Bergman et al.; licensee BioMed Central Ltd.
  •  
59.
  •  
60.
  • Bhatt, Deepak L., et al. (författare)
  • Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study
  • 2019
  • Ingår i: Clinical Cardiology. - : Wiley. - 0160-9289 .- 1932-8737. ; 42:5, s. 498-505
  • Tidskriftsartikel (refereegranskat)abstract
    • In the setting of prior myocardial infarction, the oral antiplatelet ticagrelor added to aspirin reduced the risk of recurrent ischemic events, especially, in those with diabetes mellitus. Patients with stable coronary disease and diabetes are also at elevated risk and might benefit from dual antiplatelet therapy. The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS, NCT01991795) is a Phase 3b randomized, double-blinded, placebo-controlled trial of ticagrelor vs placebo, on top of low dose aspirin. Patients >= 50 years with type 2 diabetes receiving anti-diabetic medications for at least 6 months with stable coronary artery disease as determined by a history of previous percutaneous coronary intervention, bypass grafting, or angiographic stenosis of >= 50% of at least one coronary artery were enrolled. Patients with known prior myocardial infarction (MI) or stroke were excluded. The primary efficacy endpoint is a composite of cardiovascular death, myocardial infarction, or stroke. The primary safety endpoint is Thrombolysis in Myocardial Infarction major bleeding. A total of 19 220 patients worldwide have been randomized and at least 1385 adjudicated primary efficacy endpoint events are expected to be available for analysis, with an expected average follow-up of 40 months (maximum 58 months). Most of the exposure is on a 60 mg twice daily dose, as the dose was lowered from 90 mg twice daily partway into the study. The results may revise the boundaries of efficacy for dual antiplatelet therapy and whether it has a role outside acute coronary syndromes, prior myocardial infarction, or percutaneous coronary intervention.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 51-60 av 2009
Typ av publikation
tidskriftsartikel (1236)
konferensbidrag (345)
rapport (142)
bokkapitel (85)
annan publikation (67)
doktorsavhandling (58)
visa fler...
forskningsöversikt (24)
licentiatavhandling (15)
bok (14)
samlingsverk (redaktörskap) (13)
recension (8)
proceedings (redaktörskap) (1)
visa färre...
Typ av innehåll
refereegranskat (1424)
övrigt vetenskapligt/konstnärligt (522)
populärvet., debatt m.m. (62)
Författare/redaktör
Andersson, Maria (191)
Andersson, Gerhard (46)
Johannesson, Paul (43)
Andersson, Birger (43)
Bergholtz, Maria (42)
Bokarewa, Maria, 196 ... (38)
visa fler...
Ericsson, Göran (38)
Lindh, Magnus, 1960 (38)
Andersson, Maria, 19 ... (37)
Conroy, Sean (36)
Andersson, Maria L.E ... (36)
Andersson Sundén, Er ... (35)
Weiszflog, Matthias (34)
Andersson, Göran (33)
Erlandsson, Malin, 1 ... (31)
Andersson, Karin, 19 ... (30)
Johansson, Maria (28)
Andersson, Stefan (28)
Andersson, Erik (27)
Sjöstrand, Henrik (27)
Hjalmarsson, Anders (26)
Andersson, Dan I. (24)
Kihl, Maria (24)
Andersson, Leif (23)
Wilbe, Maria (22)
Andersson, Magnus (21)
Haglund, Emma, 1970- (21)
Andersson, Maria, 19 ... (21)
Andersson, Jonas (20)
Larsson, Ingrid, 196 ... (20)
Gärling, Tommy, 1941 (19)
Riboli, Elio (19)
Andersson, Martin (18)
Weiderpass, Elisabet ... (18)
Forslind, Kristina (18)
Bremander, Ann, 1957 ... (18)
Bergman, Stefan, 195 ... (18)
Albin, Maria (18)
Weise, Cornelia (18)
Andersson, Maria, 19 ... (18)
Andersson, Maria, 19 ... (18)
Andersson, Ulrika (17)
Andersson, Staffan, ... (17)
Andersson, Roger (16)
Overvad, Kim (16)
Tumino, Rosario (16)
Edirisuriya, Ananda (16)
Ilayperuma, Tharaka (16)
Andersson, Maria, 19 ... (16)
Prager, Maria, 1973 (16)
visa färre...
Lärosäte
Lunds universitet (394)
Göteborgs universitet (392)
Uppsala universitet (365)
Karolinska Institutet (281)
Linköpings universitet (213)
Stockholms universitet (183)
visa fler...
Umeå universitet (165)
Sveriges Lantbruksuniversitet (150)
Chalmers tekniska högskola (130)
Kungliga Tekniska Högskolan (100)
Örebro universitet (81)
Högskolan i Halmstad (65)
Luleå tekniska universitet (62)
Linnéuniversitetet (57)
Karlstads universitet (51)
RISE (43)
Högskolan i Gävle (21)
VTI - Statens väg- och transportforskningsinstitut (21)
Högskolan Väst (20)
Jönköping University (20)
Högskolan i Skövde (19)
Malmö universitet (18)
Högskolan Kristianstad (17)
Högskolan Dalarna (17)
Mälardalens universitet (16)
Naturvårdsverket (13)
Gymnastik- och idrottshögskolan (12)
Högskolan i Borås (12)
Blekinge Tekniska Högskola (9)
Röda Korsets Högskola (9)
IVL Svenska Miljöinstitutet (6)
Mittuniversitetet (5)
Sophiahemmet Högskola (4)
Naturhistoriska riksmuseet (3)
Havs- och vattenmyndigheten (3)
Handelshögskolan i Stockholm (2)
Marie Cederschiöld högskola (2)
Södertörns högskola (1)
Riksantikvarieämbetet (1)
Kungl. Konsthögskolan (1)
visa färre...
Språk
Engelska (1683)
Svenska (309)
Odefinierat språk (16)
Tyska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (806)
Naturvetenskap (398)
Samhällsvetenskap (386)
Teknik (248)
Lantbruksvetenskap (122)
Humaniora (86)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy